Lakeisha Richardson, MD
Obstetrics & Gynecology · Greenville, MSNPI 1417132689
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Applied Medical Resources Corporation at 45.3% of the total. Reporting peaked in 2022 at $747 and has fallen 79.8% since, to $151 in 2025.
Across 46 payments — averaging $35.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$735
- AbbVie$315
- Astellas Pharma US Inc$241
- Pfizer$145
- Lupin Inc.$99
- Abbott$41
- plus $48 from 2 others
What the payments were for
- Travel & lodging$67942%
- Food & beverage$85353%
- Education$906%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 4 | $735 |
| AbbVie | 23 | $315 |
| Astellas Pharma US Inc | 5 | $241 |
| Pfizer | 3 | $145 |
| Lupin Inc. | 7 | $99 |
| Abbott | 1 | $41 |
| Coopersurgical, Inc. | 2 | $30 |
| Solventum Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$664
How this compares
$1,622 in reported general payments places this provider in the 60th percentile of 318 obstetrics & gynecology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OsphenaOspemifene | 11 | $2,615 |
| Estradiol | 78 | $954 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 12 | $674 |
| Solifenacin Succinate | 22 | $475 |
| Metronidazole | 22 | $372 |
| Alendronate Sodium | 65 | $323 |
| Nystatin | 16 | $237 |
| Fluconazole | 18 | $66 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Greenville
- Robert DesantisEllisville$212K
- Lori FultonJackson$102K
- Sheila BouldinJackson$56K
- Melissa BarnettTupelo$50K
- Ahmet BedestaniFlowood$41K
- Stacey KreherBay St. Louis$40K
- Joseph McGeheeTupelo$35K
- Elizabeth TarsiTupelo$21K
- Charlene CollierRidgeland$20K
- Douglas TurnerAmory$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.